THE SAINSBURY LABORATORY
Financial health, per its FY2025 accounts
The charity reported a consolidated surplus of £1,897,719 for the year ended 31 March 2025, with total unrestricted reserves of £11,427,940. The trustees maintain sufficient unrestricted reserves to ensure stability, designating £5,400,000 for long-term sustainability beyond 2029 when major donor funding is no longer secured. The accounts state there are sufficient assets to support scientific plans into the foreseeable future.
What the accounts disclose
“Trustees consider approximately three months of annual charitable spend to be a reasonable allocation of reserves to cover such a likelihood. At year end this amounted to approximately £1,500,000.”
“Appolinaire Djikeng received £12,000 (2024: £6,000) and Neil Gow received £19,500 (2024: £7,500) remuneration as Directors of Plant Science Innovations Ltd.” — page 24
“During the year The Sainsbury Laboratory was charged £924,000 (2024 £813,000) under this agreement.” — page 31
“During the year Gatsby provided £7.6m (2024: £6.4m) of funding.”
“During the year The Sainsbury Laboratory was charged £924,000 (2024 £813,000) under this agreement.” — page 31
“During the year Gatsby provided £7.6m (2024: £6.4m) of funding.”
“During the year The Sainsbury Laboratory was charged £924,000 (2024 £813,000) under this agreement.” — page 31
“During the year Gatsby provided £7.6m (2024: £6.4m) of funding.”
“During the year The Sainsbury Laboratory was charged £924,000 (2024 £813,000) under this agreement.” — page 31
“During the year Gatsby provided £7.6m (2024: £6.4m) of funding.”
“During the year The Sainsbury Laboratory was charged £924,000 (2024 £813,000) under this agreement.” — page 31
“During the year Gatsby provided £7.6m (2024: £6.4m) of funding.”
“The Sainsbury Laboratory has a 100% owned subsidiary Plant Science Innovations Ltd” — page 5
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Dr Appolinaire Djikeng
- PETER HESKETH
- Prof Neil Gow
- Professor Mark Searcey
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £14.2m | £12.3m |
| 31/03/2024 | £12.7m | £10.4m |
| 31/03/2023 | £10.8m | £10.0m |
| 31/03/2022 | £9.4m | £9.6m |
| 31/03/2021 | £10.1m | £9.4m |
Common questions
Is THE SAINSBURY LABORATORY financially healthy?
The charity reported a consolidated surplus of £1,897,719 for the year ended 31 March 2025, with total unrestricted reserves of £11,427,940. The trustees maintain sufficient unrestricted reserves to ensure stability, designating £5,400,000 for long-term sustainability beyond 2029 when major donor funding is no longer secured. The accounts state there are sufficient assets to support scientific plans into the foreseeable future. Its FY2025 accounts were audited by Crowe U.K. LLP.